◆ TICKERBASE · US STOCK FINANCIAL DATA LIBRARY

HomeAll stocks › LMRI

Lumexa Imaging Holdings, Inc. (LMRI) Financial History

4 years of revenue, earnings, cash-flow and balance-sheet history from public filings.

Healthcare · Medical Devices · DATA UPDATED 2026-07-20

Lumexa Imaging Holdings, Inc. (LMRI) operates in the Medical Devices industry and is headquartered in Raleigh, United States with about 4,064 employees. Its market capitalization is roughly $1 billion. In the fiscal year ended 2025-12-31, LMRI reported $1.0B in revenue and ($47M) in net income.

Lumexa Imaging Holdings, Inc. owns and operates diagnostic imaging centres in the United States.

Interactive charts & full statements → Open the LMRI valuation workbench →

LMRI Revenue & Earnings History — Annual Income Statement

Income statement2025-12-312024-12-312023-12-31
Total Revenue$1.0B$949M$936M
Gross Profit$158M$96M$99M
Operating Income (EBIT)$27M($16M)($13M)
Net Income($47M)($94M)($122M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LMRI Quarterly Revenue & Earnings — Last 8 Quarters

Quarterly income statement2026-03-312025-12-312025-03-312024-12-31
Total Revenue$252M$268M$245M$248M
Gross Profit$35M$42M$37M$22M
Operating Income (EBIT)$4M($8M)$10M($8M)
Net Income$2M($29M)($8M)($25M)

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

LMRI Free Cash Flow History

LMRI Balance Sheet History

Balance sheet2025-12-312024-12-312023-12-31
Total Assets$1.8B$1.7B$1.7B
Total Liabilities$1.2B$1.5B$1.5B

USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).

Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive LMRI viewer.

Other Companies in Medical Devices

← LMNRAll stocksLMT →

About TickerBase · Data methodology & sources

TickerBase is provided for educational and informational purposes only. It does not constitute financial, investment, tax, or legal advice, or a recommendation to buy, sell, or hold any security. No price targets are published; any per-share value shown in the valuation workbench is generated entirely from reader-supplied assumptions and is not the publisher's view of fair value. Past performance does not predict future results. Figures are approximate and drawn from public filings; one-time items are noted where identified. Do your own research and consult a licensed professional before making any investment decision. The author may or may not hold positions in the securities discussed.